Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
89bio Inc (NASDAQ: ETNB) closed the day trading at $9.44 up 2.28% from the previous closing price of $9.23. In other words, the price has increased by $2.28 from its previous closing price. On the day, 1.42 million shares were traded. ETNB stock price reached its highest trading level at $9.555 during the session, while it also had its lowest trading level at $9.14.
Ratios:
For a better understanding of ETNB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.19 and its Current Ratio is at 15.19. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on March 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $11.
On March 13, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 15 ’25 when Le-Nguyen Quoc sold 10,461 shares for $11.02 per share. The transaction valued at 115,280 led to the insider holds 309,364 shares of the business.
QUOC LE-NGUYEN bought 10,461 shares of ETNB for $115,233 on Jul 15 ’25. On Apr 15 ’25, another insider, Le-Nguyen Quoc, who serves as the insider of the company, sold 15,329 shares for $5.95 each. As a result, the insider received 91,208 and left with 328,323 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 1400027520 and an Enterprise Value of 876484864.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.27, which has changed by 0.08381176 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $11.84, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -4.54%, while the 200-Day Moving Average is calculated to be 8.27%.
Shares Statistics:
Over the past 3-months, ETNB traded about 1.89M shares per day on average, while over the past 10 days, ETNB traded about 1847450 shares per day. A total of 148.30M shares are outstanding, with a floating share count of 145.86M. Insiders hold about 1.65% of the company’s shares, while institutions hold 109.29% stake in the company. Shares short for ETNB as of 1753920000 were 15786388 with a Short Ratio of 8.35, compared to 1751241600 on 15815704. Therefore, it implies a Short% of Shares Outstanding of 15786388 and a Short% of Float of 14.729999.
Earnings Estimates
The current assessment of 89bio Inc (ETNB) involves the perspectives of 6.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.45 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2.01 and -$2.35 for the fiscal current year, implying an average EPS of -$2.2. EPS for the following year is -$2.29, with 9.0 analysts recommending between -$1.63 and -$2.65.
